Aequus Pharmaceuticals Inc. — Form D
Aequus Pharmaceuticals Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-26. The offering totals $629K, of which $629K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-01-26
- Form: D
- Accession: 0000950172-16-000147
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $629K
- Amount sold: $629K
- Investors: 7
- Date of first sale: 2016-01-12
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-255970
Issuer
- Name: Aequus Pharmaceuticals Inc.
- CIK: 0001664767
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2013
- Address: 2820-200 GRANVILLE STREET, VANCOUVER, A1, V6C 1S4
- Phone: (604) 336-7906
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Fotios Plakogiannis | Director | Whitestone, NY |
| HAMED SHAHBAZI | Director | VANCOUVER, A1 |
| Ian Ball | Executive Officer | Vancouver, A1 |
| Donald McAfee | Executive Officer | Vancouver, A1 |
| Christina Yip | Executive Officer | Vancouver, A1 |
| Ann Fehr | Executive Officer | Vancouver, A1 |
| Chris Clark | Director | New York, NY |
| Doug Janzen | Director | Park City, UT |
| Doug Janzen | Executive Officer | Park City, UT |
| Anne Stevens | Director | Vancouver, A1 |
| Anne Stevens | Executive Officer | Vancouver, A1 |
| Jason Flowerday | Director | Vancouver, A1 |
| Stu Fowler | Director | Vancouver, A1 |
| Rodoula Plakogiannis | Director | Vancouver, A1 |
Other filings by this issuer (1)
More